Clinical trial
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma…
NCT00017147 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00017147 |
|---|---|
| Title | S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma |
| Official title | A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System |
| Intervention type | Drug, Radiation |
| Interventions | carmustine, radiation therapy, O6-Benzylguanine |
| Enrollment | 183 |
| Start date | Sep 1, 2001 |
| Primary completion | May 1, 2006 |
| Completion | Nov 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 30, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: